FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease ...Middle East

SILVER SPRING, Md., Dec. 8, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older....

Hence then, the article about fda approves first gene therapies to treat patients with sickle cell disease was published today ( Friday 08/12/2023 - 07:40 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease )

Also on site :

• Menu-Order-AI Surpasses 110,000 Downloads as It Targets the Biggest Gap in the GLP-1 Era: What to Order
• Happy's Place Boss Teases Season 3 Plans: More Bemmett, More Jane Lynch... And More Of Steve Howey And JoAnna Garcia?
• Walmart's $15 Storage Bin 4-Pack Is 'Great for Organizing' Fridges, Pantries, and Cabinets